Antibody data
- Antibody Data
- Antigen structure
- References [9]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN967347 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Sialophorin (SPN) antibody
- Antibody type
- Monoclonal
- Antigen
- Other
- Description
- Purified from tissue culture supernatant or ascites by affinity chromatography.
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- L60
- Vial size
- 0.1 mg
- Concentration
- 0.5 mg/ml
- Storage
- 4°C
Submitted references CD43, the major sialoglycoprotein of human leukocytes, is proteolytically cleaved from the surface of stimulated lymphocytes and granulocytes.
The importance of cross-linking in the homotypic aggregation of lymphocytes induced by anti-leukosialin (CD43) antibodies.
Human neutrophils release their major membrane sialoprotein, leukosialin (CD43), during cell activation.
The "CD43 only" phenotype. An aberrant, nonspecific immunophenotype requiring comprehensive analysis for lineage resolution.
CD43 interferes with T-lymphocyte adhesion.
Cross-linking of sialophorin (CD43) induces neutrophil aggregation in a CD18-dependent and a CD18-independent way.
CD43, a molecule defective in Wiskott-Aldrich syndrome, binds ICAM-1.
Down-regulation by tumor necrosis factor-alpha of neutrophil cell surface expression of the sialophorin CD43 and the hyaluronate receptor CD44 through a proteolytic mechanism.
Enhancement of T-cell activation by the CD43 molecule whose expression is defective in Wiskott-Aldrich syndrome.
Bazil V, Strominger JL
Proceedings of the National Academy of Sciences of the United States of America 1993 May 1;90(9):3792-6
Proceedings of the National Academy of Sciences of the United States of America 1993 May 1;90(9):3792-6
The importance of cross-linking in the homotypic aggregation of lymphocytes induced by anti-leukosialin (CD43) antibodies.
Cyster JG, Williams AF
European journal of immunology 1992 Oct;22(10):2565-72
European journal of immunology 1992 Oct;22(10):2565-72
Human neutrophils release their major membrane sialoprotein, leukosialin (CD43), during cell activation.
Rieu P, Porteu F, Bessou G, Lesavre P, Halbwachs-Mecarelli L
European journal of immunology 1992 Nov;22(11):3021-6
European journal of immunology 1992 Nov;22(11):3021-6
The "CD43 only" phenotype. An aberrant, nonspecific immunophenotype requiring comprehensive analysis for lineage resolution.
Segal GH, Stoler MH, Tubbs RR
American journal of clinical pathology 1992 Jun;97(6):861-5
American journal of clinical pathology 1992 Jun;97(6):861-5
CD43 interferes with T-lymphocyte adhesion.
Ardman B, Sikorski MA, Staunton DE
Proceedings of the National Academy of Sciences of the United States of America 1992 Jun 1;89(11):5001-5
Proceedings of the National Academy of Sciences of the United States of America 1992 Jun 1;89(11):5001-5
Cross-linking of sialophorin (CD43) induces neutrophil aggregation in a CD18-dependent and a CD18-independent way.
Kuijpers TW, Hoogerwerf M, Kuijpers KC, Schwartz BR, Harlan JM
Journal of immunology (Baltimore, Md. : 1950) 1992 Aug 1;149(3):998-1003
Journal of immunology (Baltimore, Md. : 1950) 1992 Aug 1;149(3):998-1003
CD43, a molecule defective in Wiskott-Aldrich syndrome, binds ICAM-1.
Rosenstein Y, Park JK, Hahn WC, Rosen FS, Bierer BE, Burakoff SJ
Nature 1991 Nov 21;354(6350):233-5
Nature 1991 Nov 21;354(6350):233-5
Down-regulation by tumor necrosis factor-alpha of neutrophil cell surface expression of the sialophorin CD43 and the hyaluronate receptor CD44 through a proteolytic mechanism.
Campanero MR, Pulido R, Alonso JL, Pivel JP, Pimentel-Muiños FX, Fresno M, Sánchez-Madrid F
European journal of immunology 1991 Dec;21(12):3045-8
European journal of immunology 1991 Dec;21(12):3045-8
Enhancement of T-cell activation by the CD43 molecule whose expression is defective in Wiskott-Aldrich syndrome.
Park JK, Rosenstein YJ, Remold-O'Donnell E, Bierer BE, Rosen FS, Burakoff SJ
Nature 1991 Apr 25;350(6320):706-9
Nature 1991 Apr 25;350(6320):706-9
No comments: Submit comment
No validations: Submit validation data